Lilly Alzheimer's drug not to be covered by U.K.'s NHS
Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.
Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...
Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...
Medpage Today on MSN13h
Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files SuitIn Washington state, four agricultural workers tested presumptively positive for avian influenza after contact with infected ...
Mangoceuticals Inc. (MGRX) announced that Eli Lilly has made public allegations and filed a lawsuit against the company, claiming ...
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
Eli Lilly sues vendors for selling unauthorized tirzepatide amid resolved shortages. Lawsuits target vendors offering ...
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...
Mangoceuticals (MGRX) learned earlier this morning that Eli Lilly (LLY) has made certain public claims alleging, and has stated that it ...
Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...
Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback